Breakthrough Infection by SARS-CoV-2 Delta and Omicron Variants Elicited Immune Response Comparable to mRNA Booster Vaccination

J Infect Dis. 2022 Sep 21;226(6):1122-1124. doi: 10.1093/infdis/jiac275.

Authors

Suvichada Assawakosri^{1

2}, Nungruthai Suntronwong¹, Ritthideach Yorsaeng¹, Sitthichai Kanokudom^{1

2}, Nasamon Wanlapakorn¹, Sittisak Honsawek², Yong Poovorawan^{1

3}

Affiliations

¹ Center of Excellence in Clinical Virology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
² Center of Excellence in Osteoarthritis and Musculoskeleton, Faculty of Medicine, Chulalongkorn University, King Chulalongkorn Memorial Hospital, Thai Red Cross Society, Bangkok, Thailand.
³ 3 FRS(T), the Royal Society of Thailand, Sanam Sueapa, Dusit, Bangkok, Thailand.

No abstract available

Publication types

Editorial
Research Support, Non-U.S. Gov't
Comment

MeSH terms

COVID-19* / prevention & control
Humans
Immunity, Humoral*
RNA, Messenger
SARS-CoV-2 / genetics
Vaccination

Substances

RNA, Messenger

Supplementary concepts

SARS-CoV-2 variants